Top

Critical Care

Published in:

Open Access 01-06-2010 | Research

Regulation and prognostic relevance of serum ghrelin concentrations in critical illness and sepsis

Authors: Alexander Koch, Edouard Sanson, Anita Helm, Sebastian Voigt, Christian Trautwein, Frank Tacke

Published in: Critical Care | Issue 3/2010

Abstract

Introduction

Ghrelin has been recently identified as a mediator of various beneficial effects in animal models of sepsis. At present, no data are available concerning specific properties of ghrelin in critically ill patients from large cohorts. In order to identify possible pathogenic functions of ghrelin in critically ill patients and human sepsis from a clinical point of view, we aimed at analyzing ghrelin serum concentrations in a large cohort of well characterized patients with critical illness.

Methods

A total of 170 critically ill patients (122 with sepsis, 48 without sepsis) were studied prospectively on admission to the Medical intensive care unit (ICU) and compared to 60 healthy controls. Careful assessment of clinical data, various laboratory parameters, metabolic and endocrine functions as well as investigational inflammatory cytokine profiles have been performed, and patients were followed for approximately three years.

Results

Ghrelin serum concentrations are elevated in critically ill patients as compared to healthy controls, but do not differ between sepsis and non-sepsis patients. The underlying etiologies of critical diseases are not associated with ghrelin serum levels. Neither pre-existing diabetes mellitus nor body mass index is correlated to serum ghrelin concentrations. Ghrelin is not correlated to markers of inflammation or hepatic function in critically ill patients. In the subgroup of non-sepsis patients, ghrelin correlates inversely with renal function and markers of carbohydrate metabolism. High ghrelin levels are an indicator for a favourable prognosis concerning mortality at the ICU in sepsis patients. Furthermore, ghrelin is significantly associated with the necessity of ventilation in critically ill patients.

Conclusions

Ghrelin serum concentrations are elevated in all circumstances of critical disease, including sepsis and non-sepsis patients. High ghrelin levels are a positive predictor of ICU-survival in sepsis patients, matching previous results from animal models. Future experimental and clinical studies are needed to evaluate ghrelin as a novel prognostic tool in ICU patients and its potential therapeutic use in sepsis.

Available only for authorised users

Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K: Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999, 402: 656-660. 10.1038/45230CrossRefPubMed

Shuto Y, Shibasaki T, Wada K, Parhar I, Kamegai J, Sugihara H, Oikawa S, Wakabayashi I: Generation of polyclonal antiserum against the growth hormone secretagogue receptor (GHS-R): evidence that the GHS-R exists in the hypothalamus, pituitary and stomach of rats. Life Sci 2001, 68: 991-996. 10.1016/S0024-3205(00)01001-8CrossRefPubMed

Papotti M, Ghe C, Cassoni P, Catapano F, Deghenghi R, Ghigo E, Muccioli G: Growth hormone secretagogue binding sites in peripheral human tissues. J Clin Endocrinol Metab 2000, 85: 3803-3807. 10.1210/jc.85.10.3803PubMed

Hattori N, Saito T, Yagyu T, Jiang BH, Kitagawa K, Inagaki C: GH, GH receptor, GH secretagogue receptor, and ghrelin expression in human T cells, B cells, and neutrophils. J Clin Endocrinol Metab 2001, 86: 4284-4291. 10.1210/jc.86.9.4284CrossRefPubMed

Ariyasu H, Takaya K, Tagami T, Ogawa Y, Hosoda K, Akamizu T, Suda M, Koh T, Natsui K, Toyooka S, Shirakami G, Usui T, Shimatsu A, Doi K, Hosoda H, Kojima M, Kangawa K, Nakao K: Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab 2001, 86: 4753-4758. 10.1210/jc.86.10.4753CrossRefPubMed

Krsek M, Rosicka M, Haluzik M, Svobodova J, Kotrlikova E, Justova V, Lacinova Z, Jarkovska Z: Plasma ghrelin levels in patients with short bowel syndrome. Endocr Res 2002, 28: 27-33. 10.1081/ERC-120004535CrossRefPubMed

Wang G, Lee HM, Englander E, Greeley GH Jr: Ghrelin--not just another stomach hormone. Regul Pept 2002, 105: 75-81. 10.1016/S0167-0115(02)00012-5CrossRefPubMed

Wiley KE, Davenport AP: Comparison of vasodilators in human internal mammary artery: ghrelin is a potent physiological antagonist of endothelin-1. Br J Pharmacol 2002, 136: 1146-1152. 10.1038/sj.bjp.0704815PubMedCentralCrossRefPubMed

van der Lely AJ, Tschop M, Heiman ML, Ghigo E: Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev 2004, 25: 426-457. 10.1210/er.2002-0029CrossRefPubMed

10.

Klok MD, Jakobsdottir S, Drent ML: The role of leptin and ghrelin in the regulation of food intake and body weight in humans: a review. Obes Rev 2007, 8: 21-34. 10.1111/j.1467-789X.2006.00270.xCrossRefPubMed

11.

Wu R, Dong W, Zhou M, Cui X, Simms HH, Wang P: Ghrelin improves tissue perfusion in severe sepsis via downregulation of endothelin-1. Cardiovasc Res 2005, 68: 318-326. 10.1016/j.cardiores.2005.06.011CrossRefPubMed

12.

Wu R, Dong W, Cui X, Zhou M, Simms HH, Ravikumar TS, Wang P: Ghrelin down-regulates proinflammatory cytokines in sepsis through activation of the vagus nerve. Ann Surg 2007, 245: 480-486. 10.1097/01.sla.0000251614.42290.edPubMedCentralCrossRefPubMed

13.

Wu R, Dong W, Qiang X, Wang H, Blau SA, Ravikumar TS, Wang P: Orexigenic hormone ghrelin ameliorates gut barrier dysfunction in sepsis in rats. Crit Care Med 2009, 37: 2421-2426. 10.1097/CCM.0b013e3181a557a2PubMedCentralCrossRefPubMed

14.

Wu R, Dong W, Zhou M, Zhang F, Marini CP, Ravikumar TS, Wang P: Ghrelin attenuates sepsis-induced acute lung injury and mortality in rats. Am J Respir Crit Care Med 2007, 176: 805-813. 10.1164/rccm.200604-511OCPubMedCentralCrossRefPubMed

15.

Wang W, Bansal S, Falk S, Ljubanovic D, Schrier R: Ghrelin protects mice against endotoxemia-induced acute kidney injury. Am J Physiol Renal Physiol 2009, 297: F1032-1037. 10.1152/ajprenal.00044.2009CrossRefPubMed

16.

Fink MP: Sepsis, ghrelin, the cholinergic anti-inflammatory pathway, gut mucosal hyperpermeability, and high-mobility group box 1. Crit Care Med 2009, 37: 2483-2485. 10.1097/CCM.0b013e3181abf5f4CrossRefPubMed

17.

Vila G, Maier C, Riedl M, Nowotny P, Ludvik B, Luger A, Clodi M: Bacterial endotoxin induces biphasic changes in plasma ghrelin in healthy humans. J Clin Endocrinol Metab 2007, 92: 3930-3934. 10.1210/jc.2007-1194CrossRefPubMed

18.

Nematy M, O'Flynn JE, Wandrag L, Brynes AE, Brett SJ, Patterson M, Ghatei MA, Bloom SR, Frost GS: Changes in appetite related gut hormones in intensive care unit patients: a pilot cohort study. Crit Care 2006, 10: R10. 10.1186/cc3957PubMedCentralCrossRefPubMed

19.

Koch A, Gressner OA, Sanson E, Tacke F, Trautwein C: Serum resistin levels in critically ill patients are associated with inflammation, organ dysfunction and metabolism and may predict survival of non-septic patients. Crit Care 2009, 13: R95. 10.1186/cc7925PubMedCentralCrossRefPubMed

20.

Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101: 1644-1655. 10.1378/chest.101.6.1644CrossRefPubMed

21.

Wu R, Zhou M, Cui X, Simms HH, Wang P: Upregulation of cardiovascular ghrelin receptor occurs in the hyperdynamic phase of sepsis. Am J Physiol Heart Circ Physiol 2004, 287: H1296-1302. 10.1152/ajpheart.00852.2003CrossRefPubMed

22.

Yilmaz Z, Ilcol YO, Ulus IH: Endotoxin increases plasma leptin and ghrelin levels in dogs. Crit Care Med 2008, 36: 828-833. 10.1097/01.CCM.0B013E3181611F5AACrossRefPubMed

23.

Tacke F, Brabant G, Kruck E, Horn R, Schoffski P, Hecker H, Manns MP, Trautwein C: Ghrelin in chronic liver disease. J Hepatol 2003, 38: 447-454. 10.1016/S0168-8278(02)00438-5CrossRefPubMed

24.

Peeters TL: Ghrelin: a new player in the control of gastrointestinal functions. Gut 2005, 54: 1638-1649. 10.1136/gut.2004.062604PubMedCentralCrossRefPubMed

25.

Basa NR, Wang L, Arteaga JR, Heber D, Livingston EH, Tache Y: Bacterial lipopolysaccharide shifts fasted plasma ghrelin to postprandial levels in rats. Neurosci Lett 2003, 343: 25-28. 10.1016/S0304-3940(03)00312-4CrossRefPubMed

26.

Chang L, Zhao J, Yang J, Zhang Z, Du J, Tang C: Therapeutic effects of ghrelin on endotoxic shock in rats. Eur J Pharmacol 2003, 473: 171-176. 10.1016/S0014-2999(03)01972-1CrossRefPubMed

27.

Maruna P, Gurlich R, Frasko R, Rosicka M: Ghrelin and leptin elevation in postoperative intra-abdominal sepsis. Eur Surg Res 2005, 37: 354-359. 10.1159/000090336CrossRefPubMed

28.

Tschop M, Smiley DL, Heiman ML: Ghrelin induces adiposity in rodents. Nature 2000, 407: 908-913. 10.1038/35038090CrossRefPubMed

29.

Wren AM, Small CJ, Ward HL, Murphy KG, Dakin CL, Taheri S, Kennedy AR, Roberts GH, Morgan DG, Ghatei MA, Bloom SR: The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 2000, 141: 4325-4328. 10.1210/en.141.11.4325CrossRefPubMed

30.

Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS: A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 2001, 50: 1714-1719. 10.2337/diabetes.50.8.1714CrossRefPubMed

31.

Tschop M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML: Circulating ghrelin levels are decreased in human obesity. Diabetes 2001, 50: 707-709. 10.2337/diabetes.50.4.707CrossRefPubMed

32.

Shiiya T, Nakazato M, Mizuta M, Date Y, Mondal MS, Tanaka M, Nozoe S, Hosoda H, Kangawa K, Matsukura S: Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab 2002, 87: 240-244. 10.1210/jc.87.1.240CrossRefPubMed

33.

Mesotten D, Van den Berghe G: Changes within the growth hormone/insulin-like growth factor I/IGF binding protein axis during critical illness. Endocrinol Metab Clin North Am 2006, 35: 793-805. ix-x 10.1016/j.ecl.2006.09.010CrossRefPubMed

34.

Takala J, Ruokonen E, Webster NR, Nielsen MS, Zandstra DF, Vundelinckx G, Hinds CJ: Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 1999, 341: 785-792. 10.1056/NEJM199909093411102CrossRefPubMed

35.

Nagaya N, Kojima M, Uematsu M, Yamagishi M, Hosoda H, Oya H, Hayashi Y, Kangawa K: Hemodynamic and hormonal effects of human ghrelin in healthy volunteers. Am J Physiol Regul Integr Comp Physiol 2001, 280: R1483-1487.PubMed

Title: Regulation and prognostic relevance of serum ghrelin concentrations in critical illness and sepsis
Authors: Alexander Koch
Edouard Sanson
Anita Helm
Sebastian Voigt
Christian Trautwein
Frank Tacke
Publication date: 01-06-2010
Publisher: BioMed Central
Published in: Critical Care / Issue 3/2010
Electronic ISSN: 1364-8535
DOI: https://doi.org/10.1186/cc9029

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Regulation and prognostic relevance of serum ghrelin concentrations in critical illness and sepsis

Abstract

Introduction

Methods

Results

Conclusions

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Introduction

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 3/2010

Hypertension may be the most important component of hyperdynamic therapy in cerebral vasospasm

Urinary cystatin C is diagnostic of acute kidney injury and sepsis, and predicts mortality in the intensive care unit

The role of angiogenic factors in predicting clinical outcome in severe bacterial infection in Malawian children

Pulmonary and renal protection: targeting PARP to ventilator-induced lung and kidney injury?

Arterial pressure-based cardiac output in septic patients: different accuracy of pulse contour and uncalibrated pressure waveform devices

Hypercapnia and hypokalemia in near-death experiences